Initial high-dose β-blockers toleration with reduced ejection fraction heart failure of hospitalized hypertensive patients
Prescriptions of initial high-dose BB in hypertensive patients with HFrEF were not associated with an increased incidence of adverse safety outcomes. These findings indicate that initial high-dose BB therapy could be a viable strategy for this population.
Authors
- Xiangyu Yang (ORCID: https://orcid.org/0000-0002-4373-7630)
- Xinran Li (ORCID: https://orcid.org/0000-0001-8988-7223)
- Xiaoping Chen (ORCID: https://orcid.org/0000-0001-8725-6591)
- Yilin Zhou (ORCID: https://orcid.org/0009-0000-4748-8865)
- Si Wang (ORCID: https://orcid.org/0000-0002-4456-6706)
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-12-15
- DOI
- https://doi.org/10.3389/fcvm.2025.1672940
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sichuan University
- West China Hospital, Sichuan University